R1	Has_value Arg1:T1 Arg2:T2	
R2	Has_qualifier Arg1:T1 Arg2:T3	
R3	Has_value Arg1:T5 Arg2:T4	
R4	Has_value Arg1:T7 Arg2:T8	
R5	Has_negation Arg1:T10 Arg2:T11	
R6	Has_value Arg1:T12 Arg2:T17	
R8	Has_value Arg1:T26 Arg2:T27	
R9	Has_value Arg1:T23 Arg2:T24	
R10	Has_value Arg1:T21 Arg2:T22	
*	OR T21 T23
R7	Has_value Arg1:T28 Arg2:T29	
R11	Has_negation Arg1:T31 Arg2:T30	
R12	Subsumes Arg1:T26 Arg2:T28	
R13	Subsumes Arg1:T10 Arg2:T21	
R14	Has_value Arg1:T13 Arg2:T17	
R15	Has_value Arg1:T14 Arg2:T17	
R16	Has_value Arg1:T15 Arg2:T17	
R17	Has_value Arg1:T16 Arg2:T17	
T1	Measurement 14 26	Ph (BCR/ABL)
T2	Value 27 35	positive
T3	Qualifier 36 43	de novo
T4	Value 44 54	< 55 years
T5	Person 55 58	old
T6	Non-representable 59 128	(it is advisable to include patients over 55 years LAL07OPH protocol)
T7	Measurement 131 149	Performance status
T8	Value 150 153	0-2
T10	Condition 255 286	functional impairment of organs
T9	Non-representable 154 235	(Appendix B) may include patients with performance status > 2 attributable to LAL
T11	Negation 247 254	without
T12	Measurement 304 319	total bilirubin
T13	Measurement 321 324	AST
T14	Measurement 326 329	ALT
T15	Measurement 331 338	alfa-GT
T16	Measurement 343 363	alkaline phosphatase
T17	Value 364 407	less than 3 times the upper limit of normal
T21	Measurement 435 451	serum creatinine
T22	Value 452 461	< 2 mg/dL
T23	Measurement 465 485	clearance creatinine
T24	Value 486 497	> 30 ml/min
T25	Non-representable 498 541	(except renal function attributable to LAL)
T26	Measurement 542 558	cardiac function
T27	Value 572 578	normal
T28	Measurement 580 594	ventricular EF
T29	Value 595 600	> 50%
T30	Negation 602 612	absence of
T31	Condition 613 647	severe chronic respiratory disease
T34	Non-representable 649 805	In the event that alterations are secondary to the disease is at the discretion of the investigator to determine if the patient can be included in the trial
